研选现货Candor Bioscience：LowCross® HRP（低交叉反应-HRP结合物稳定剂）

保存条件 ：2-8°C

保质期 ：请询

英文名 ：Candor Bioscience：LowCross® HRP

库存 ：部分现货库存

供应商 ：青木生物技术（武汉）有限公司

CAS号 ：N/A

规格 ：50 ml/125 ml/500 ml

HRP gives peroxidase-antibody conjugates the crucial long-term stability over several years even in a ready-to-use dilution. You will be positively surprised about the enhanced long-term stability of your antibody-peroxidase-conjugates.

LowCross-Buffer® stands for superior reliability by antagonising assay interferences including HAMA-derived ones.
The efficient HAMA blocking activity of LowCross-Buffer® now also includes superior HRP-stabilization components. The result is an assay diluent for peroxidase conjugates with high reliability and convenience due to ready-to-use dilution.


文献引用：

• C. Mazziotta et al. (2021). Decreased IgG Antibody Response to Viral Protein Mimotopes of Oncogenic in Cell Polyomavirus in Sera From Healthy Elderly Subjects." Frontiers in Immunology (2021): 4206. M. Park et al. (2021).
• Valproic acid protects intestinal organoids against radiation via NOTCH signaling. Cell Biology International. doi.org/10.1002/cbin.11591 D. Johnson et al. (2021).
• Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain. Scientific Reports, 11(1), 1-12. V. D. Gonzalez et al. (2021).
• High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment. Cell Reports, 36(9), 109632. D. Junker et al. (2021).
• Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay. medRxiv. doi.org/10.1101/2021.08.20.21262328 M. Lehmann et al. (2021).
• Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunology, 1-12. R. Kant et al. (2021).
• Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime. medRxiv. doi.org/10.1101/2021.08.06.21261716 C. F. Fotis et al. (2021).
• Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach. Scientific reports, 11(1), 1-11. S. Mohandas et al. (2021). Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model. BioRxiv. doi.org/10.1101/2021.02.25.432136